Mission Creek Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,808
Closed -$1.46M 237
2024
Q3
$1.46M Buy
2,808
+99
+4% +$52.9K 0.34% 89
2024
Q2
$1.47M Buy
2,709
+1,397
+106% +$738K 0.37% 79
2024
Q1
$680K Buy
1,312
+470
+56% +$234K 0.18% 134
2023
Q4
$397K Sell
842
-25
-3% -$11.6K 0.1% 167
2023
Q3
$377K Sell
867
-14
-2% -$6.35K 0.13% 164
2023
Q2
$392K Sell
881
-43
-5% -$19.8K 0.13% 169
2023
Q1
$425K Sell
924
-507
-35% -$241K 0.14% 162
2022
Q4
$734K Sell
1,431
-65
-4% -$33K 0.26% 114
2022
Q3
$679K Buy
1,496
+1
+0.1% +$478 0.26% 114
2022
Q2
$722K Sell
1,495
-10
-0.7% -$4.95K 0.24% 119
2022
Q1
$739K Sell
1,505
-5
-0.3% -$2.29K 0.2% 139
2021
Q4
$700K Buy
1,510
+1
+0.1% +$421 0.14% 150
2021
Q3
$563K Sell
1,509
-100
-6% -$38K 0.1% 165
2021
Q2
$614K Sell
1,609
-40
-2% -$15.3K 0.1% 143
2021
Q1
$592K Sell
1,649
-75
-4% -$24.1K 0.09% 145
2020
Q4
$554K Hold
1,724
0.17% 135
2020
Q3
$463K Sell
1,724
-132
-7% -$35.5K 0.18% 137
2020
Q2
$488K Buy
1,856
+11
+0.6% +$2.94K 0.26% 96
2020
Q1
$419K Sell
1,845
-80
-4% -$21.8K 0.23% 99
2019
Q4
$581K Buy
+1,925
New +$530K 0.27% 99

Other funds holding ELV

Mission Creek Capital Partners's ELV Position: Q4 2024 in Review

Mission Creek Capital Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2,808 shares — an estimated $1.46M sold.

Mission Creek Capital Partners first reported a position in ELV in Q4 2019 and held it in 20 quarters. The position peaked at $1.47M in Q2 2024. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Mission Creek Capital Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Mission Creek Capital Partners sold 2,808 Elevance Health shares in Q4 2024, an estimated $1.46M.
  • Mission Creek Capital Partners first reported a position in Elevance Health in Q4 2019 and held it in 20 quarters.
  • Mission Creek Capital Partners's Elevance Health position peaked at $1.47M in Q2 2024.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Mission Creek Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.